logo-loader
NASDAQ:ADVM

Adverum Biotechnlogies Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$713.15 m
Price
8.95 USD
Change
4.92%
52 weeks high
16.81
52 weeks low
4.22

In brief

Adverum Biotechnologies Inc (ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases.